Member Exclusive

Histone deacetylase inhibitors: a potential epigenetic treatment for Duchenne muscular dystrophy

Epigenomics Review of the rationale behind the use of an epigenetic therapy as a potential pharmacological treatment of Duchenne muscular dystrophy, by Silvia Consalvi, Valentina Saccone and Chiara Mozzetta, from IRCCS Santa Lucia Foundation and CNR Institute of Cellular Biology & Neurobiology (both Rome, Italy).

Go to the profile of RegMedNet
Dec 05, 2016

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.


No comments yet.